Resonant Medical Technologies (Toronto, ON)

CMDF Investment: $7,500,000.00
CMDF II Investment: $3,000,000.00
Focus: Cancer  
www.resonantmedical.com

Resonant Medical is a private Canadian medical imaging company founded in 2000 with operations in Montreal and Toronto. The company focuses on cancer therapy's major ongoing concern of how to visualize; analyze and adapt to the constantly changing state of tumors during the course of treatment. These capabilities are crucially needed by physicians in order to ensure the precise delivery of radiation and chemotherapy to tumors while sparing healthy surrounding tissues. To achieve this breakthrough; Resonant Medical is pioneering the field of 3D Ultrasound Image-Guided Adaptive Cancer Therapy. Resonant's hardware-software platform verifies tumor position and treatment accuracy and will also detect if; when and how a treatment plan has to be adapted to compensate for daily changes in tumor state. By acquiring 3D tumor data at both the treatment planning & delivery stages; Resonant provides the new ability to utilize such data in the same coordinate space over time; and enhance treatments accordingly. This enables an eagerly-awaited "See and Treat" paradigm shift that will improve cancer treatment quality and reduce its side effects.